Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study

2011 ◽  
Vol 411 (1-2) ◽  
pp. 78-85 ◽  
Author(s):  
Ilva D. Rupenthal ◽  
Colin R. Green ◽  
Raid G. Alany
2020 ◽  
Vol 10 (5-s) ◽  
pp. 32-39
Author(s):  
Fatima Eram ◽  
, Vivek

Objectives: The purpose of this research was to develop the micro emulsion-based in situ gelling systems containing Ciprofloxacin for prophylaxis and treatment of the posterior segment diseases like endophthalmitis. Methods: Ciprofloxacin was encapsulated in small droplets owing to form microemulsion, and then the formed droplets were dispersed in a polymer solution that converted into a gel upon triggered by the electrolyte present in the tear fluid. Results: The formulation approach provides better absorption, penetration, retention, and improves the bioavailability of the drug. The average concentration reached into vitreous humor from topical microemulsion in situ gelling formulation was ~0.4 µg/ml, which is far more than the concentration required for therapeutic effect (i.e.  >0.047 µg/ml or >MIC90 for S. Epidermidis, a pathogen commonly responsible to cause endophthalmitis). Conclusion: Thus, novel micro emulsion-based in situ gelling formulation could be a potential drug delivery system for the treatment of posterior segment diseases like endophthalmitis. Keywords: Microemulsion, ciprofloxacin, endophthalmitis, ocular, infection, in situ


Drug Delivery ◽  
2014 ◽  
Vol 23 (1) ◽  
pp. 63-68 ◽  
Author(s):  
Zichao Luo ◽  
Ling Jin ◽  
Lu Xu ◽  
Zhao Liang Zhang ◽  
Jing Yu ◽  
...  

2016 ◽  
Vol 502 (1-2) ◽  
pp. 70-79 ◽  
Author(s):  
Kosai Al Khateb ◽  
Elvira K. Ozhmukhametova ◽  
Marat N. Mussin ◽  
Serzhan K. Seilkhanov ◽  
Tolebai K. Rakhypbekov ◽  
...  

2019 ◽  
Vol 24 (8) ◽  
pp. 1575-1586 ◽  
Author(s):  
Karim A. Soliman ◽  
K Ullah ◽  
A. Shah ◽  
David S. Jones ◽  
Thakur R.R. Singh

2013 ◽  
Vol 40 (2) ◽  
pp. 90 ◽  
Author(s):  
Divya Kumar ◽  
Upendra Nagaich ◽  
Neha Gulati ◽  
Nidhi Jain

2019 ◽  
Vol 9 (1) ◽  
pp. 337-347 ◽  
Author(s):  
Asmat Majeed ◽  
Nisar Ahmad Khan

Eye is the most sensitive organ of the body. Designing of ocular drug delivery system is the  most challenging field for pharmaceutical scientists as less than 5% of administered drug enters the eye due to the complicated anatomical structure of the eye, small absorptive surface and low transparency of the cornea, lipophilicity of corneal epithelium, pre corneal loss (due to nasolacrimal drainage), bonding of the drug with proteins contained in tear fluid, blinking, low capacity of conjunctival sac, that restricts the entry of drug molecule at the site of action and ultimately leads to poor ocular therapy. To improve ophthalmic drug bioavailability, there are considerable efforts directed towards newer drug delivery systems for ophthalmic administration. These novel drug delivery systems offer manifold advantages over conventional systems as they increase the efficiency of drug delivery by improving the release profile and also reduce drug toxicity. A lot of research going on in this area proves the fact that in situ gelling systems can be beneficial in the ocular drug delivery. In situ gel forming systems are drug delivery systems that are in solution form before administration in the body but once administered, undergo  in situ gelation, to form a gel triggered by external stimulus such as temperature, pH etc.  This review is to Specify a brief summary about in situ gels, various approaches for in situ gelling systems, different types of polymers used in in situ gels, their mechanisms of gel formation and evaluation of polymeric in situ gel. Keywords: in situ gel, polymers, Temperature induced in situ gel system, pH induced in situ gel system, Ion activated systems.


Sign in / Sign up

Export Citation Format

Share Document